Introduction
taking steroids or other drugs that affect cytokine metabolcytoplasmatic segment and appears to be important ism. Control samples were obtained partly from healthy for transducing the action of IL-1; the type II (p68) volunteers belonging to the personnel of the Division of receptor is found mainly on neutrophils, monocytes, Nephrology of Varese, and partly from individuals with bone marrow cells, and B lymphocytes, has a shorter normal renal function seen periodically because of primary cytoplasmatic segment and no intrinsic biological activ-hypertension who were on low-salt diet and were not taking ity [34 ] . IL-1 bound to IL-1 receptor type I is rapidly any hypotensive medications. They were 16 females and 11 internalized, remains inside the cells for as long as 12 males. Their average age was 59.2 years (range . h, and only a small amount is degraded, whereas IL-1 bound to type II receptor is poorly internalized, Plasma preparation remains long on the surface and is rapidly degraded [33 ] . Whenever IL-1 is produced, the synthesis of a Predialysis samples were taken immediately before the session natural inhibitor [35 ] , which has been named IL-1 after the long interval; postdialysis samples were taken from receptor antagonist (IL-1ra), occurs as well [36 ] . The the arterial line just before the end of the session. Any dilution of blood specimens was thus prevented. Plasma for IL-1ra is a polypeptide which is closely related to IL-1.
IL-1b and IL-1ra determination was obtained by centrifuIt has the same molecular size and is produced by the gation of haeparinized blood. After centrifugation, plasma same cells. The IL-1ra blocks IL-1 by binding to the was aspirated and spun at 4°C, 5000 g, for 10 min. The cellular receptors without activating them, thus pre-supernatant was stored, frozen at −85°C, until tested for venting the binding and consequent biological effects IL-1b and IL-1ra concentration. of IL-1 [33, 34] . Increased production and elevated plasma levels of IL-1ra have been described in haemo-Cell preparation dialysis patients [9, 37] while data on cellular IL-1 receptors are lacking. Biological activities of IL-1 thus Haeparinized blood was centrifuged on a Ficoll-Hypaque results from an interplay and balance between the gradient (Pharmacia Diagnostics, Piscataway, NJ ). Monoactive molecule, the binding to its cellular receptors, nuclear cells were washed three times with medium RPMI the number and type of receptors expressed by target 1640 (Gibco, Grand Island, NY ) with the addition of polycells, and the inhibitory action of its antagonists. myxin B (5 mg/ml ) and penicillin/streptomycin. Cells were then resuspended in 1 ml of culture medium prepared as
The aim of the present study was to evaluate the above supplemented with 10% fetal calf serum, brought to a expression of the IL-1 receptor on lymphocytes and concentration of 5×106 cells/ml and incubated for 6 h at monocytes as well as the intradialytic kinetics of plasma 37°C in 5% CO 2 atmosphere. Cultures were harvested and and cellular IL-1b and IL-1ra content in uraemic cells resuspended and submitted to three cycles of freezing patients undergoing haemodialysis using different (−85°C ) and thawing. After the third cycle cells were spun membranes.
at 5000 g and the supernatant was stored frozen at −85°C until tested.
Subjects and methods

Quantification of lymphocytes and monocytes expressing the IL-1 receptor Patients
The IL-1 receptor expression was studied by the use of a commercial IL-1b flow cytometry kit ( IL-1b Fluorokine kit, Two groups of 10 uraemic patients each undergoing maintenance haemodialysis by means of either high-flux polysulphone R & D Systems Inc. Minneapolis, MN ) which measures the binding of IL-1b to cell-surface receptor. PBMC were centri-( 1.25 m2 F60, Fresenius, Concord, Ca) or cuprophane (1.30 m2, Asahi Medical Co., Tokyo, Japan) hollow-fibre haemo-fuged and washed twice with culture medium with the addition of polymyxin B at a concentration of 5 mg/ml. Cells dialysis membranes were studied. The patients were on renal replacement treatment at the Division of Nephrology of were then resuspended in the same medium and brought to a final concentration of 4×106 cells/ml. Cells were incubated Varese and gave their informed consent to the study. The whole uraemic patient population included eight males and with recombinant IL-1b conjugated to biotin for 60 min in siliconized glass tubes and then were washed to remove 12 females, their mean age was 65.4 years (range 42-81) and the average duration of haemodialysis was 44 months (range unbound cytokine. Subsequently cells were incubated with fluorescin-isothiocyanate conjugated avidin. Then they were 19-71). There were no differences in gender, age, and duration of haemodialysis between the two groups of patients. washed to remove unbound avidin-FITC and resuspended in PBS for flow cytometric analysis by an EPICS Profile flow Each haemodialysis session had a duration of 4 h 30 min; new dialysers were employed in every case; no critical acute cytometer (Coulter Corporation, Hieleah, FL). The gates were adjusted to include the lymphocyte and the monocytes adverse reactions to the dialysis procedure were observed, and the total ultrafiltration was always kept below 3% of the clusters. The gates were set up by using monoclonal antibodies against KC562 (pan-leukocyte marker), CD2 ( T cells), predialysis body weight. All patients were on treatment with recombinant erythropoietin at doses adjusted to keep a CD 19 ( B cells), MO2 (monocyte). The specificity of the binding was tested by preincubating cells with a 20-, 50-and constant Hct between 30 and 35%. All patients had an internal a-v fistula as vascular access. Patients dialysed on 100-fold molar excess of unconiugated rIL-1b prior to incubation with biotinylated IL-1b. The IL-1 binding by cuprophane had always been treated by means of the same type of membrane. Patients dialysed on polysulphone had these cells was compared with that of another set of cells that were incubated only with biotinylated IL-1b. As shown either always been treated with that membrane, or been so treated for a minimum of 6 months preceding the study. in Figure 1 , preincubation with different concentrations of unconiugated rIL-1b reduced the percentage of IL-1b-binding They were all free from infections and none of them was IL-l, IL-l receptor and IL-lra interplay in haemodialysis 113 binding cells in the control population. The difference is extremely significant (P<0.0001).
IL-1 receptors during haemodialysis
No differences in the expression of IL-1 receptor on both lymphocytes and monocytes were seen between groups of uraemic patients chronically treated by sity of receptors per cell as expressed by fluorescence intensity did not change.
Enzyme immunoassay for IL-1b and IL-1ra
Cytokines levels (pg/ml ) were measured by enzyme immunoassays for human IL-1b and IL-1ra (Quantikine, R & D Systems Inc. Minneapolis, MN ). The quantitative 'sandwich' immunoassay was employed. Briefly, a monoclonal antibody specific for IL-1b or IL-1ra had been previously coated onto 96 flat-bottomed microtitre plates. Samples were pipetted into the wells and the cytokine, if any, was bound by the antibody. Subsequently an enzyme-linked polyclonal antibody specific for IL-1b (or IL-1ra) was added to complete the sandwich. A substrate solution was then added and the optical density was measured with a spectrophotometer ( Titertek Multiskan MC, EFlab, Oy, Helsinki, Finland) set at 450 nm.
Statistical analysis
Results are expressed as mean ±1 SEM. The unpaired t test was employed to compare independent data. The paired t Fig. 2 . Proportions of peripheral lymphocytes expressing the IL-1 test was employed for paired data. Differences were consid-receptor prior to and at the end of a haemodialysis session with ered significant when P<0.05.
cuprophane (n=10) and polysulphone (n=10).
Results
Expression of IL-1 receptors on peripheral blood mononuclear cells in controls and HD patients
The absolute number as well as the relative proportion of peripheral leukocytes and their subsets after 4 h 30 min of haemodialysis with both cuprophane and polysulphone were indistinguishable from the predialysis values.
The proportion of cells in the lymphocyte clusters that bound recombinant IL-1b on their cytoplasmic membrane in end-stage renal-disease patients (n=20) was 2.9±0.9%. In controls (n=27) 3.1±1.0% of lymphocytes bound recombinant IL-1. The difference was not significant.
In the monocyte clusters of uraemic patients, how- Fig. 3 . Proportions of peripheral monocytes expressing the IL-1 ever, 31.5±3.5% of the cells bound IL-1 on their receptor prior to and at the end of a haemodialysis session with cuprophane (n=10) and polysulphone (n=10). cellular membrane compared with 8.7±1.9% IL-1
Plasma levels of IL-1ra in controls and HD patients Non-uraemic controls had plasma levels of IL-1ra below or at the detection limit of the method ( 23 pg/ml ). Plasma levels of IL-1ra in haemodialysis patients were instead extremely high (720±134 pg/ml ) ranging from a minimum value of 150 pg/ml to a maximum of 2700 pg/ml.
The difference between the two groups of 10 patients each treated with either cuprophane (797±242 pg/ml ) or polysulphone ( 643±140 pg/ml ) was not significant.
Plasma IL-1ra during haemodialysis
As shown in Figure 4 , plasma levels of IL-1ra increased during the haemodialysis session in both groups of at the end of a haemodialysis session with cuprophane (n=10) and The rate of increse was similar regardless of polysulphone (n=10 ). whether cuprophane (from 797±242 pg/ml to 1163±254 pg/ml; P<0.05) or polysulphone (from 643±125 pg/ml to 1012±130 pg/ml; P<0.05) was seen in both groups of haemodialysed patients there employed. Changes of plasma IL-1ra, however, were are differences depending upon the membrane emnot homogeneous among individual patients, since in ployed. In fact with cuprophane IL-1ra increaed from two cases of each membrane group IL-1ra concentra-960±143 to 1,880±324 pg/ml (P<0.0005) while with tion decreased.
polysulphone the rate of increase was lower, from 923±131 to 1,310±183 pg/ml (P<0.04). Total cellular IL-1ra in controls and HD patients Plasma levels of IL-1b in controls and in HD patients The amount of IL-1ra, expressed as pg/ml per 5×106 cell in 1 ml of medium, measured in control individuals Plasma levels of IL-1b in control subjects were at or was 544±134 pg/ml vs 941±94 pg/ml in haemodialy-below the detection limit of the method (31 pg/ml ). In sis patients (P<0.02). There was no difference be-haemodialysis patients predialysis plasma concentratween cuprophane-and polysulphone-treated patients tions of IL-1b were 1314±210 pg/ml (range 140-3300 ) ( 960±143 and 923±131 pg/ml respectively, pre-with an extremely significant difference with the condialysis values). trols (P<0.0001). Predialysis plasma levels of IL-1b of patients treated by means of two different haemodialysis membranes were slightly but not significantly Total cellular IL-1ra during haemodialysis different (1397±309 pg/ml with cuprophane vs IL-1ra further increased during haemodialysis from 1231±298 pg/ml with polysulphone). 941±94 up to 1595±193 pg/5×106 cells/ml (P< 0.0001). Figure 5 shows that whereas the intradialytic Plasma IL-1b kinetics during haemodialysis increase of this parameter during haemodialysis was Figure 6 shows that plasma concentration of IL-1b decreased thoughout haemodialysis in every individual patient. The differences of the means were significant in both cases, since IL-1b concentration fell from 1397±309 pg/ml to 491±136 pg/ml with cuprophane (P<0.002) and from 1231±298 pg/ml to 407±80 pg/ml with polysulphone (P<0.02).
Total cellular IL-1b in controls and HD patients
Results of IL-1b concentration are expressed as pg/ml of IL-1b per 5×106 PBMC in 1 ml of medium. The IL-1b concentration was significantly higher in haemodialysis patients than in the control group (598±58 vs 411±65 pg/5×106 cells respectively; P<0.05).
Total cellular IL-1b during hemodialysis a predialysis level of 663±86 pg/5×106 cell/ml to on their cytoplasmic membrane increases during a haemodialysis session carried out by means of cuprophane but not of polysulphone membranes. IL-1 receptor expression is an early marker of cell activation; thus the results of the present study provide evidence that monocytes are chronically activated in haemodialysis patients. Since IL-1 is produced by activated cells, the high number of monocytes expressing the IL-1 receptor indicates that in haemodialysis there is an increased availability of activated monocytes which are both producers and targets of IL-1. Both B and T lymphocytes express the IL-1 receptor following activation [29, 30] . Our study shows that the proportion of peripheral lymphocytes of uraemic patients on maintenance haemodialysis expressing the IL-1 receptor is low and similar to that of healthy haemodialysis membrane is employed. Since IL-1 cannot exert its activity in the absence of its receptor on cellular membrane, our data indicate that the high levels of IL-1 do not play a direct role in the changes of lymphocyte function associated with chronic haemodialysis. These results are consistent with earlier studies showing no signs of activation on resting lymphocytes of uraemic patients, both in vivo and in vitro [38 ] . Our data also support the previous observation that the upregulation of the high-affinity IL-2 receptor induced in vitro by the uraemic serum on normal lymphocytes occurs by a mechanism which is independent by circulating IL-1 [39] .
Upon activation, monocytes produce both IL-1 and its inhibitor, the IL-1 receptor antagonist [34, 35] . In our study the average of both IL-1b and IL-1ra plasma levels are significantly higher in haemodialysis patients than in non-uraemic individuals whose plasma levels an extremely large distribution of values of both cytokines among individuals, which prevents our results a postdialysis level of 829±74 pg/5×106 cell/ml from having a general application to the condition of (P<0.003). With polysulphone there was a lesser chronic haemodialysis as such. Implications of cytokine but still significant increase from 558±75 to measurements during haemodialysis have been recently 719±83 pg/5×106 cell/ml; (P<0.05), (Figure 7 ) . reviewed [40] . Some investigators found high predialysis plasma levels of IL-1b [5] [6] [7] [8] [9] 12, 41] ; other groups of investigators, however, did not find such Discussion elevated plasma IL-1b levels [22] [23] [24] . These discrepances may have several explanations. Firstly, the method employed. Bioassays based on The biological activity of IL-1 depends on the number and type of its receptors on target cells and the amount T cell, B cell, or thymocyte proliferations are highly sensitive; however, other cytokines possibly present in of its naturally occurring inhibitors [28, 33, 34] .
The present study demonstrates that the autocrine plasma (mainly IL-6 but also IL-2, IL-4, and IL-7) can stimulate cell proliferation in a bioassay [3, 26 ] loop of IL-1 is activated in monocytes but not in lymphocytes of patients undergoing chronic mainten-with consequent overestimation of the results.
Conversely, low IL-1 activity in a bioassay may result ance haemodialysis. In our study we show that in haemodialysed patients the number of monocytes bind-from the presence of inhibitors in plasma of haemodialysis patients. IL-1 levels measured by the use of ing recombinant IL-1 is significantly higher than in healthy individuals. As far as the role of the haemodia-radioimmune-assays (RIA) may give lower values than those determined with enzyme-linked immunosorbent lysis membrane is concerned, the small number of cases per group does not permit definite conclusions; assays ( ELISA), since RIAs appear to be up to 10 times less sensitive [7] . ELISAs have been shown to however, there is a trend which suggests that the proportion of monocytes expressing the IL-1 receptor be sensitive and highly correlated with bioassays whose
In our study the spontaneous production of IL-1b recombinant IL-1b with that of rIL-4 and rIL-6 [7] . In order to check the specificity or other possible in haemodialysis patients is greater than in the control group. Mononuclear cells obtained after 4 h 30 min of disturbances of the immunoassay, we retested for IL1b and IL-1ra random plasma and medium from cell haemodialysis are associated with higher amounts of IL-1b and IL-1ra than the predialysis samples. This culture samples after they had been incubated for 2 h in anti-IL-1b, IL-1ra, IL-2 precoated or uncoated wells. indicates a de novo production of both cytokines during the course of the haemodialysis encounter. The absoAfter incubation with anti-IL-1b and anti-IL-1ra, concentrations of IL-1b and IL-1ra were on average 30% lute concentrations as well as rates of intradialytic increase of IL-1ra are higher than those of IL-1b. of their original value, whereas there were no changes of IL-1b and IL-1ra in the samples preincubated with Predialysis IL-1ra plasma levels, however, are lower than IL-1b. During the course of a haemodialysis anti-IL-2 or in uncoated wells ( Figure 8) .
Secondly, the selection of patients and the already encounter, IL-1b and IL-1ra have different kinetics. Whereas plasma concentration of IL-1b decreases in mentioned large interpatient variability of results. In the present study plasma IL-1b concentration in every individual patient, with an average of 35% of the predialysis value, plasma concentration of IL-1ra haemodialysis patients ranged from 140 to 3300 pg/ml. Other investigators found IL-1b values ranging from further increases. It has been shown that once IL-1b is produced, relevant amounts of it remain in the 160 to 1700 pg/ml [9] or from undetectable values to nearly 20 000 pg/ml [12] .
intracellular compartments and its release may require up to 72 h to equal the intracellular rate [8, 33] . Some Thirdly, the large distribution of values may result from differences in the duration of treatment with random samples of cell cultures of the present study were tested in order to measure separately the haemodialysis. In the present work we investigated patients who had undergone haemodialysis for a min-intracellular and extracellular IL-1b and IL-1ra concentrations. The amount of IL-1ra released in the imum of 19 months. Earlier studies have shown that uraemic patients not yet dialysed have no detectable supernatant of the cell cultures was relatively higher than that of IL-1b (39 vs 18% of the total cytokine IL-1b in their plasma and that levels of the cytokine progressively increase with the duration of regular measured), which is consistent with results of other investigators who have shown that the synthesis of ILhaemodialysis treatment [7, 8] .
Fourthly, poorly nourished and anaemic patients 1b and IL-1ra by mononuclear cells does not follow a unique pathway and that IL-1ra is much more readily have an impaired ability to produce cytokines [3 ] which is significantly improved by treatment with secreted than IL-1b [43] . It is then likely that postdialysis plasma samples contain much of the de novo erythropoietin [42 ] . The high levels of IL-1b in our study may then also be explained by the fact that all IL-1ra produced, whereas release of IL-1b occurs mostly during the interdialytic stretches. the patients were receiving erythropoietin.
Lastly, other factors such as coexisting infectious or Haemodialysis membranes are able to remove circulating IL-1b by mechanisms which involve ultrafiltration and adsorbtion [21] . In our study plasma IL-1b levels decreased during haemodialysis sessions with both low-flux cuprophane and high-flux polysulphone, while others found no change with cuprophane and slight, non-significant decrease with polysulphone [12 ], or intradialytic increase with both more or less biocompatible membranes [7 ] or opposite kinetics during dialysis with cuprophane and polyacrylonitrile membranes [6 ] . The discrepancies with data of other studies are to be explained.
Firstly, as already stated, the large variability of predialysis levels impairs the generalizibility of our results, and such limitation is even stronger in the case of analysis of membrane groups which include small number of patients. Secondly, the predialysis level may affect the results of the intradialytic kinetics. Thirdly, an important role can be played by the rate of dehydratation applied during the haemodialysis session that Fig. 8 . IL-1b and IL-1ra levels, in both plasma (solid lines) and cell in our study was very low ( less than 3% of body culture medium (dashed lines), in a typical experiment in which weight). Moreover, despite the different clearance by cytokines are measured by ELISA, as described in the Subjects and convective transport between cuprophane and polysulmethods section ( basal ) and after 2 h of preincubation at room phone membranes, adsorbtion of IL-1b may occur temperature in wells coated with an antibody, anti IL-1b, anti IL-1ra, anti IL-2, or in uncoated wells.
with all membranes contributing to remove the cyto-kine from circulation as some studies have shown not decrease. However, production and kinetics of IL1b and IL-1ra are not uniform and do not follow a [8, 21, 44] .
Whereas synthetic membranes, in particular hydro-unique pathway. Accordingly any conclusion must be drawn with caution and may not be always suitable phobic membranes, adsorb more proteins than cellulosic membranes [4] , it has been shown that during for general application.
During the course of a haemodialysis session uraemic normal use of a new cellulosic dialysers, as in the present study, coating of the membrane with a protein patients often suffer from otherwise unexplained hypotensive episodes, sudden occurrence of chills, or fever. film occurs as well [45, 46] , making otherwise different membranes similar in terms of permeability to some Chronically treated haemodialysis patients are, in high proportion, affected by osteopenia, loss of body mass, substances [47 ] . According to our study such clearing and binding properties of the haemodialysis mem-accelerated atherosclerosis, and a unique form of b 2 -microglobulin amyloidosis. Given its peculiar intradiabranes do not seem to apply to IL-1ra. Although IL1b and IL-1ra share many similarities in terms of lytic kinetics it is likely that, at least in stable patients, free from acute massive bacterial contamination, IL-1 chemical structure and molecular size, IL-1ra might not necessarily have the same affinity for the dialysis is more involved in the chronic than in the acute complications of the extracorporeal renal replacement membranes as IL-1b.
Since elevated amounts of IL-1 receptor antagonist treatments. Changes of immunocompetence of chronic haemodialysis might not be mediated by the abnormal are produced by mononuclear cells of haemodialysed patients, circulate in their plasma, and compete for IL-1 activity. The high IL-1ra levels appear to be mostly an expression of the inflammatory state which binding to the cellular IL-1 receptors, balance between IL-1b and IL-1ra is crucial to allow the biological haemodialysis somewhat resembles, rather than to have a protective role. Besides monocytes and lymphocytes, activity of IL-1b. Based on the current available studies we should conclude that the IL-1b effects largely a large variety of cells express the IL-1 receptor, including endothelial cells, chondrocytes, fibroblasts, prevail on those of IL-1ra. In fact it has been shown that as much as 100-fold excess of IL-1ra is required and synovial lining cells [33 ] . Studies of such cells as target of IL-1 action might be useful in the understandto inhibit IL-1-induced responses of T lymphocytes and of other target cells [48, 49] . Those values are ing of the multifactorial pathology which accompanies uraemia. much higher than those we measured in our study even in the postdialysis period when the IL-1b/IL-1ra ratio decreases.
